Conventional and Kampo Medicine Treatment for Mild-to-moderate COVID-19: A Multicenter, Retrospective, Observational Study by the Integrative Management in Japan for Epidemic Disease (IMJEDI Study-observation)

Shin Takayama*, Tetsuhiro Yoshino, Sayaka Koizumi, Yasuhito Irie, Tomoko Suzuki, Susumu Fujii, Rie Katori, Mosaburo Kainuma, Seiichi Kobayashi, Tatsuya Nogami, Kenichi Yokota, Mayuko Yamazaki, Satoko Minakawa, Shigeki Chiba, Norio Suda, Yoshinobu Nakada, Tatsuya Ishige, Hirofumi Maehara, Yutaka Tanaka, Mahiko NagaseAkihiko Kashio, Kazuhisa Komatsu, Makoto Nojiri, Osamu Shimooki, Kayo Nakamoto, Ryutaro Arita, Rie Ono, Natsumi Saito, Akiko Kikuchi, Minoru Ohsawa, Hajime Nakae, Tadamichi Mitsuma, Masaru Mimura, Tadashi Ishii, Kotaro Nochioka, Shih Wei Chiu, Takuhiro Yamaguchi, Takao Namiki, Akito Hisanaga, Kazuo Mitani, Takashi Ito

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Conventional and Kampo Medicine Treatment for Mild-to-moderate COVID-19: A Multicenter, Retrospective, Observational Study by the Integrative Management in Japan for Epidemic Disease (IMJEDI Study-observation)'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science